Summary

Nutraceuticals Market By Product Type (Dietary Supplements [Vitamins and Minerals, Amino Acids and Proteins, Herbal Supplements, Omega 3 and Fatty Acids, Enzymes], Functional Foods [Fortified Foods, Prebiotic and Probiotic, Functional Snacks and Bars, Nutritional Powders and Mixes], Functional Beverages [Sports Drinks, Energy drinks, Fortified Juices, Tea and Coffee, Diary Based Beverages]), By Form (Tables and Capsules, Powders, Liquids, Gummies & Chewable, Others), By Distribution channel (Supermarkets and Hypermarkets, Pharmacies & Drug Stores, Online Stores, Other) And By Age Group (Infants and toddlers (0 to 3yrs), Children (4 to 12), Adolescents (13 to 19), Adults (20 to 59), Seniors Citizens (60+)), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 ? 2035
The Nutraceuticals Market accounted for USD 451.8 billion in 2024 and is expected to reach USD 831.3 billion by 2035, growing at a CAGR of around 5.7% between 2025 and 2035. The nutraceuticals market covers a wide range of products, such as dietary supplements, functional foods, and functional beverages that preserve certain health benefits apart from basic nutrition. These products are capable of supporting the well-being of individual consumers, preventing chronic diseases, and improving physical and mental performance. The industry is gaining strong growth, propelled by rising health awareness, an aging population, and a growing trend toward preventive healthcare. Innovating developments in personalized nutrition, clean-label formulations, and digital health integration are shaping consumers' expectations. Forecasts remain buoyantly optimistic for the nutraceuticals industry, with demand profusely increasing from both the developed and developing markets. Companies aim toward backing science-based, transparent offerings for building trust and gaining market share.
R&D and Product Innovations
Nutraceutical innovation continuously brings opportunities in development, from contraceptive ideas to application-based technologies. Firms are working towards setting up R&D for custom formulations to tackle particular health issues. Recent advancements in biotechnology and science are said to have produced bioavailable and effective products. Consumers are increasingly drawn towards clean-label, plant-based, and personalized nutrition. Hence, the brands tend to focus more on transparency and scientific validation. These innovations are improving both the efficacy and building consumer trust and brand loyalty.
High Cost of Raw Materials
Many nutraceutical products rely on high-quality, natural ingredients that suffer from price fluctuations and supply chain constraints. Ingredients such as botanical extracts and specialized proteins are often associated with high production and sourcing costs. The requirement of purity and traceability adds to the burden substantially. Certification expenses prove to be additional deterrents for companies promoting organic or clean-label products. Such costs are usually transferred to consumers, which adds to limiting the accessibility of nutraceuticals to a wider demographic. Thus, price sensitivity becomes a challenge, especially in the developing market.
Expansion in Emerging Markets
Emerging economies provide ample financial opportunity because of improved health care awareness and growing disposable income. Urbanization ensures there are more people exposed to various global wellness trends and modern retail formats. Governments and NGOs are also helping by promoting nutrition education and preventive care initiatives. The local players have developed product lines catering to culture-sensitive health issues. International players are partnering strategically and using e-commerce channels to enter these markets. This expansion is expected to create an alternative source of revenue and heighten overall market growth.
Segment Analysis
Nutraceuticals can be found in a variety of forms, which include tablets, capsules, powders, gummies, and liquids. Tablets and capsules are most favorable for their ease of dosage and longer shelf life for consumption. Most fitness enthusiasts will prefer powders since they will allow them to measure their serving sizes, and it is absorbed very quickly. Gummies are fast becoming a favorite, especially for younger demographics and those looking for more palatable alternatives. Liquids and ready-to-drink forms are even beginning to shoot for growth due only to their convenience and fast-acting properties. Form factor usually sways consumer preference, and the most important parts are how well it tastes, ease of use, and portability. Innovative delivery formats are being explored by manufacturers to improve compliance and experience. This segment is important for differentiation in an ever-crowded market.
Nutraceuticals are available through pharmacies, supermarkets/hypermarkets, specialty stores, and online channels as distribution channels. Although pharmacies are still a great source for supplements, considering some of their types target specific health conditions, supermarkets and hypermarkets manage the market demands of casual buyers needing fortified food and beverages as part of their everyday shopping. Specialty health and wellness stores are where informed consumers go to find premium, niche, or organic products. However, the online distribution channel offers more because these are growing rapidly in convenience, product variety, and more focused marketing. Now, direct-to-consumer brands are employing e-commerce to provide individual and subscription services. Access to product reviews and expert advice is possible using digital platforms. This change will remodel how consumers discover, evaluate, and purchase nutraceutical products.
Regional Analysis
One of the other high-potential nutraceuticals markets is Asia Pacific, with increasing health awareness on the backdrop of rapid economic growth. The blend of traditional medicine and modern supplementation brings exciting and unique products to market. Increased expenditure on health and wellness products is characteristic of the rising middle-class populations of the region. Demand for herbal supplements and functional foods is escalating in countries such as India, China, and Japan. Local manufacturers are strengthening their presence with region-specific formulations. Regulatory support and government awareness campaigns would mean further market adoption. This region is expected to become the focus of attention for global nutraceutical brands.
Competitive Landscape
The nutraceuticals market is quite competitive, filled with a mix of multinational giants and innovative startups fighting for share. Indeed, this battleground is created with product innovation, brand credibility, and quality assurance. While many have their privileges in terms of excellent distribution networks and brand loyalty, smaller brands have made disruptive moves through niche targeting and personalized solutions with clean-label offerings. Mergers and acquisitions, as well as strategic collaborations, are popularly seen by firms doing this and seeking to strengthen capabilities in geographical offerings. In the future, investment in research and development will be one of the main strategies used by companies to stay ahead in the market. Digital marketing and direct-to-consumer channels are also reshaping competitive dynamics. Meanwhile, agility and adaptability are emerging as the strongest competitive differentiators as consumer preferences evolve.
By Product
- Dietary Supplements
- Vitamins and Minerals
- Amino Acids and Proteins
- Herbal Supplements
- Omega-3 and Fatty Acids
- Enzymes
- Functional Foods
- Fortified Foods
- Prebiotic and Probiotic
- Functional Snacks and Bars
- Nutritional Powders and Mixes
- Functional Beverages
- Sports Drinks
- Energy drinks
- Fortified Juices
- Tea and Coffee
- Diary-Based Beverages
By Form
- Tablets and Capsules
- Powders, Liquids
- Gummies & Chewable
- Others
By Distribution Channel
- Supermarkets and Hypermarkets
- Pharmacies & Drug Stores
- Online Stores
- Other
By Age Group
- Infants and toddlers (0 to 3 years)
- Children (4 to 12)
- Adolescents (13 to 19)
- Adults (20 to 59)
- Senior Citizens (60+)

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Nutraceuticals Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Rising elderly population globally
3.2.2. Shifts towards healthier lifestyles, including dietary modifications, exercise regimes, and mindfulness about mental health
3.2.3. Growing awareness among consumers about preventive healthcare
3.3. Key industry pitfalls & challenges
3.3.1. Risk of potential side-effects if not consumed appropriately
3.3.2. Intense competition based on pricing, brand recognition, and product differentiation
3.3.3. Limited robust clinical evidence supporting the efficacy and health benefits of nutraceutical products
3.4. Market Opportunities
3.4.1. Expansion in Emerging Markets
3.4.2. Surge in the utility of e-commerce platforms and direct-to-consumer sales models
3.4.3. Integration of nutraceutical ingredients into everyday food and beverage products
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Nutraceuticals Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Dietary Supplements
4.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.2. Vitamins and Minerals
4.2.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.3. Amino Acids and Proteins
4.2.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.4. Herbal Supplements
4.2.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.5. Omega 3 and Fatty Acids
4.2.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.2.6. Enzymes
4.2.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3. Functional Foods
4.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.2. Fortified Foods
4.3.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.3. Prebiotic and Probiotic
4.3.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.4. Functional Snacks and Bars
4.3.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3.5. Nutritional Powders and Mixes
4.3.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4. Functional Beverages
4.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4.2. Sports Drinks
4.4.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4.3. Energy drinks
4.4.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4.4. Fortified Juices
4.4.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4.5. Tea and Coffee
4.4.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4.6. Diary Based Beverages
4.4.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5. Nutraceuticals Market, Form Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Form, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Tablets and Capsules
5.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.3. Powders
5.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.4. Liquids
5.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.5. Gummies & Chewable
5.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.6. Others
5.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6. Nutraceuticals Market, Distribution Channel Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Supermarkets and Hypermarkets
6.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6.3. Pharmacies & Drug Stores
6.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6.4. Online Stores
6.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6.5. Other
6.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7. Nutraceuticals Market, Age Group Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Age Group, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Infants and toddlers (0 to 3yrs)
7.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.3. Children (4 to 12)
7.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.4. Adolescents (13 to 19)
7.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.5. Adults (20 to 59)
7.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.6. Seniors Citizens (60+)
7.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8. Nutraceuticals Market, Region Segment Analysis
8.1. Overview
8.1.1. Global Market Revenue Share, By Region, 2025 & 2035
8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)
8.2. North America
8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)
8.2.2. North America Market Revenue, By Product Type, 2025-2035
8.2.3. North America Market Revenue, By Form, 2025-2035
8.2.4. North America Market Revenue, By Distribution Channel, 2025-2035
8.2.5. North America Market Revenue, By Age Group, 2025-2035
8.2.6. The U.S.
8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.6.2. U.S. Market Revenue, By Form, 2025-2035
8.2.6.3. U.S. Market Revenue, By Distribution Channel, 2025-2035
8.2.6.4. U.S. Market Revenue, By Age Group, 2025-2035
8.2.7. Canada
8.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.7.2. U.S. Market Revenue, By Form, 2025-2035
8.2.7.3. U.S. Market Revenue, By Distribution Channel, 2025-2035
8.2.7.4. U.S. Market Revenue, By Age Group, 2025-2035
8.3. Europe
8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)
8.3.2. Europe Market Revenue, By Product Type, 2025-2035
8.3.3. Europe Market Revenue, By Form, 2025-2035
8.3.4. Europe Market Revenue, By Distribution Channel, 2025-2035
8.3.5. Europe Market Revenue, By Age Group, 2025-2035
8.3.6. Germany
8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035
8.3.6.2. Germany Market Revenue, By Form, 2025-2035
8.3.6.3. Germany Market Revenue, By Distribution Channel, 2025-2035
8.3.6.4. Germany Market Revenue, By Age Group, 2025-2035
8.3.7. France
8.3.7.1. France Market Revenue, By Product Type, 2025-2035
8.3.7.2. France Market Revenue, By Form, 2025-2035
8.3.7.3. France Market Revenue, By Distribution Channel, 2025-2035
8.3.7.4. France Market Revenue, By Age Group, 2025-2035
8.3.8. U.K.
8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035
8.3.8.2. U.K. Market Revenue, By Form, 2025-2035
8.3.8.3. U.K. Market Revenue, By Distribution Channel, 2025-2035
8.3.8.4. U.K. Market Revenue, By Age Group, 2025-2035
8.3.9. Italy
8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035
8.3.9.2. Italy Market Revenue, By Form, 2025-2035
8.3.9.3. Italy Market Revenue, By Distribution Channel, 2025-2035
8.3.9.4. Italy Market Revenue, By Age Group, 2025-2035
8.3.10. Spain
8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035
8.3.10.2. Spain Market Revenue, By Form, 2025-2035
8.3.10.3. Spain Market Revenue, By Distribution Channel, 2025-2035
8.3.10.4. Spain Market Revenue, By Age Group, 2025-2035
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
8.3.11.2. Rest of Europe Market Revenue, By Form, 2025-2035
8.3.11.3. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035
8.3.11.4. Rest of Europe Market Revenue, By Age Group, 2025-2035
8.4. Asia Pacific
8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)
8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.3. Asia Pacific Market Revenue, By Form, 2025-2035
8.4.4. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
8.4.5. Asia Pacific Market Revenue, By Age Group, 2025-2035
8.4.6. China
8.4.6.1. China Market Revenue, By Product Type, 2025-2035
8.4.6.2. China Market Revenue, By Form, 2025-2035
8.4.6.3. Canada Market Revenue, By Distribution Channel, 2025-2035
8.4.6.4. Canada Market Revenue, By Age Group, 2025-2035
8.4.7. Japan
8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035
8.4.7.2. Japan Market Revenue, By Form, 2025-2035
8.4.7.3. Japan Market Revenue, By Distribution Channel, 2025-2035
8.4.7.4. Japan Market Revenue, By Age Group, 2025-2035
8.4.8. India
8.4.8.1. India Market Revenue, By Product Type, 2025-2035
8.4.8.2. India Market Revenue, By Form, 2025-2035
8.4.8.3. India Market Revenue, By Distribution Channel, 2025-2035
8.4.8.4. India Market Revenue, By Age Group, 2025-2035
8.4.9. Australia
8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035
8.4.9.2. Australia Market Revenue, By Form, 2025-2035
8.4.9.3. Australia Market Revenue, By Distribution Channel, 2025-2035
8.4.9.4. Australia Market Revenue, By Age Group, 2025-2035
8.4.10. South Korea
8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035
8.4.10.2. South Korea Market Revenue, By Form, 2025-2035
8.4.10.3. South Korea Market Revenue, By Distribution Channel, 2025-2035
8.4.10.4. South Korea Market Revenue, By Age Group, 2025-2035
8.4.11. Singapore
8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035
8.4.11.2. Singapore Market Revenue, By Form, 2025-2035
8.4.11.3. Singapore Market Revenue, By Distribution Channel, 2025-2035
8.4.11.4. Singapore Market Revenue, By Age Group, 2025-2035
8.4.12. Rest of Asia Pacific
8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.12.2. Rest of Asia Pacific Market Revenue, By Form, 2025-2035
8.4.12.3. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
8.4.12.4. Rest of Asia Pacific Market Revenue, By Age Group, 2025-2035
8.5. Latin America
8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)
8.5.2. Latin America Market Revenue, By Product Type, 2025-2035
8.5.3. Latin America Market Revenue, By Form, 2025-2035
8.5.4. Latin America Market Revenue, By Distribution Channel, 2025-2035
8.5.5. Latin America Market Revenue, By Age Group, 2025-2035
8.5.6. Brazil
8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.6.2. Brazil Market Revenue, By Form, 2025-2035
8.5.6.3. Brazil Market Revenue, By Distribution Channel, 2025-2035
8.5.6.4. Brazil Market Revenue, By Age Group, 2025-2035
8.5.7. Argentina
8.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.7.2. Brazil Market Revenue, By Form, 2025-2035
8.5.7.3. Brazil Market Revenue, By Distribution Channel, 2025-2035
8.5.7.4. Brazil Market Revenue, By Age Group, 2025-2035
8.5.8. Mexico
8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035
8.5.8.2. Mexico Market Revenue, By Form, 2025-2035
8.5.8.3. Mexico Market Revenue, By Distribution Channel, 2025-2035
8.5.8.4. Mexico Market Revenue, By Age Group, 2025-2035
8.5.9. Rest of Latin America
8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
8.5.9.2. Rest of Latin America Market Revenue, By Form, 2025-2035
8.5.9.3. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035
8.5.9.4. Rest of Latin America Market Revenue, By Age Group, 2025-2035
8.6. MEA
8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)
8.6.2. MEA Market Revenue, By Product Type, 2025-2035
8.6.3. MEA Market Revenue, By Form, 2025-2035
8.6.4. MEA Market Revenue, By Distribution Channel, 2025-2035
8.6.5. MEA Market Revenue, By Age Group, 2025-2035
8.6.6. GCC Countries
8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035
8.6.6.2. GCC Countries Market Revenue, By Form, 2025-2035
8.6.6.3. GCC Countries Market Revenue, By Distribution Channel, 2025-2035
8.6.6.4. GCC Countries Market Revenue, By Age Group, 2025-2035
8.6.7. South Africa
8.6.7.1. South Africa Countries Market Revenue, By Product Type, 2025-2035
8.6.7.2. South Africa Countries Market Revenue, By Form, 2025-2035
8.6.7.3. South Africa Countries Market Revenue, By Distribution Channel, 2025-2035
8.6.7.4. South Africa Countries Market Revenue, By Age Group, 2025-2035
8.6.8. Rest of Middle-East Africa
8.6.8.1. Rest of Middle-East Africa Countries Market Revenue, By Product Type, 2025-2035
8.6.8.2. Rest of Middle-East Africa Countries Market Revenue, By Form, 2025-2035
8.6.8.3. Rest of Middle-East Africa Countries Market Revenue, By Distribution Channel, 2025-2035
8.6.8.4. Rest of Middle-East Africa Countries Market Revenue, By Age Group, 2025-2035
9. Company Profile
9.1. Nestlé S.A.
9.1.1. Business Overview
9.1.2. Financial Performance
9.1.3. Product/Service Offerings
9.1.4. Strategies & recent developments
9.1.5. SWOT Analysis
9.2. General Mills, Inc.
9.2.1. Business Overview
9.2.2. Financial Performance
9.2.3. Product/Service Offerings
9.2.4. Strategies & recent developments
9.2.5. SWOT Analysis
9.3. Kellogg Company
9.3.1. Business Overview
9.3.2. Financial Performance
9.3.3. Product/Service Offerings
9.3.4. Strategies & recent developments
9.3.5. SWOT Analysis
9.4. PepsiCo, Inc.
9.4.1. Business Overview
9.4.2. Financial Performance
9.4.3. Product/Service Offerings
9.4.4. Strategies & recent developments
9.4.5. SWOT Analysis
9.5. The Kraft Heinz Company
9.5.1. Business Overview
9.5.2. Financial Performance
9.5.3. Product/Service Offerings
9.5.4. Strategies & recent developments
9.5.5. SWOT Analysis
9.6. Danone S.A.
9.6.1. Business Overview
9.6.2. Financial Performance
9.6.3. Product/Service Offerings
9.6.4. Strategies & recent developments
9.6.5. SWOT Analysis
9.7. Pfizer Inc.
9.7.1. Business Overview
9.7.2. Financial Performance
9.7.3. Product/Service Offerings
9.7.4. Strategies & recent developments
9.7.5. SWOT Analysis
9.8. Amway Corporation (Alticor Inc.)
9.8.1. Business Overview
9.8.2. Financial Performance
9.8.3. Product/Service Offerings
9.8.4. Strategies & recent developments
9.8.5. SWOT Analysis
9.9. Nature’s Bounty
9.9.1. Business Overview
9.9.2. Financial Performance
9.9.3. Product/Service Offerings
9.9.4. Strategies & recent developments
9.9.5. SWOT Analysis
9.10. Archer Daniels Midland Company
9.10.1. Business Overview
9.10.2. Financial Performance
9.10.3. Product/Service Offerings
9.10.4. Strategies & recent developments
9.10.5. SWOT Analysis
9.11. BASF SE
9.11.1. Business Overview
9.11.2. Financial Performance
9.11.3. Product/Service Offerings
9.11.4. Strategies & recent developments
9.11.5. SWOT Analysis
9.12. Hero Group
9.12.1. Business Overview
9.12.2. Financial Performance
9.12.3. Product/Service Offerings
9.12.4. Strategies & recent developments
9.12.5. SWOT Analysis
9.13. Cargill, Incorporated
9.13.1. Business Overview
9.13.2. Financial Performance
9.13.3. Product/Service Offerings
9.13.4. Strategies & recent developments
9.13.5. SWOT Analysis
9.14. DSM
9.14.1. Business Overview
9.14.2. Financial Performance
9.14.3. Product/Service Offerings
9.14.4. Strategies & recent developments
9.14.5. SWOT Analysis
9.15. Hain Celestial Group
9.15.1. Business Overview
9.15.2. Financial Performance
9.15.3. Product/Service Offerings
9.15.4. Strategies & recent developments
9.15.5. SWOT Analysis
9.16. Red Bull GmbH
9.16.1. Business Overview
9.16.2. Financial Performance
9.16.3. Product/Service Offerings
9.16.4. Strategies & recent developments
9.16.5. SWOT Analysis
9.17. Now Health Group, Inc. (NOW Foods)
9.17.1. Business Overview
9.17.2. Financial Performance
9.17.3. Product/Service Offerings
9.17.4. Strategies & recent developments
9.17.5. SWOT Analysis
9.18. Barilla Group
9.18.1. Business Overview
9.18.2. Financial Performance
9.18.3. Product/Service Offerings
9.18.4. Strategies & recent developments
9.18.5. SWOT Analysis
9.19. Raisio Group
9.19.1. Business Overview
9.19.2. Financial Performance
9.19.3. Product/Service Offerings
9.19.4. Strategies & recent developments
9.19.5. SWOT Analysis
9.20. Freedom Food Group Limited
9.20.1. Business Overview
9.20.2. Financial Performance
9.20.3. Product/Service Offerings
9.20.4. Strategies & recent developments
9.20.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. GLOBAL NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 2. GLOBAL NUTRACEUTICALS MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 3. GLOBAL NUTRACEUTICALS MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 4. GLOBAL NUTRACEUTICALS MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 5. GLOBAL NUTRACEUTICALS MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 6. GLOBAL NUTRACEUTICALS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 7. GLOBAL NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 8. GLOBAL NUTRACEUTICALS MARKET VALUE FOR CONSUMER ELECTRONICS, 2025-2035 (USD BILLION)
TABLE 9. GLOBAL NUTRACEUTICALS MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 10. GLOBAL NUTRACEUTICALS MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 11. GLOBAL NUTRACEUTICALS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 12. NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 13. NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 14. NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 15. U.S NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 16. U.S NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 17. CANADA NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 18. CANADA NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 19. EUROPE NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 20. EUROPE NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 21. EUROPE NUTRACEUTICALS MARKET VALUE, DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 22. GERMANY NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 23. GERMANY NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 24. U.K NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 25. U.K NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 26. FRANCE NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 27. FRANCE NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 28. ITALY NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 29. ITALY NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 30. SPAIN NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 31. SPAIN NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 32. ROE NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 33. ROE NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 34. ASIA PACIFC NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 35. ASIA PACIFC NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 36. ASIA PACIFC NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 37. CHINA NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 38. CHINA NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 39. INDIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 40. INDIA NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 41. JAPAN NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 42. JAPAN NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 43. REST OF APAC NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 44. REST OF APAC NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 45. REST OF WORLD NUTRACEUTICALS MARKET VALUE, BY FORM, 2025-2035 (USD BILLION)
TABLE 46. REST OF WORLD NUTRACEUTICALS MARKET VALUE, BY DISTRIBUTION CHANNEL, 2025-2035 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54. BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS